Get news updates from AACRMeetingNews.org
Subscribe below to get email updates from AACRMeetingNews.org
-
Promising study results reported in first clinical trials plenary
Researchers reported promising results from five studies, including the first cancer vaccine trial to demonstrate clinical benefit in melanoma, which was reported by Jeffrey S. Weber, MD, PhD, during the first clinical trials plenary session at the Annual Meeting.
-
Trial results suggest new approaches to treat rare cancers
In the second clinical trials plenary session at the Annual Meeting, positive results were reported from four more studies. Timothy A. Yap, MD, PhD, reported on a study that provides the first clinical proof-of-concept for effectively drugging the Hippo-YAP pathway.
-
Schedule highlights from the Program Chair: Tuesday, April 18
Annual Meeting Program Committee Chair Robert H. Vonderheide, MD, DPhil, shares a few highlights from Tuesday’s schedule to help you plan your day.
-
AACR President connects the past and future of cancer research during address
During her presidential address Sunday evening, AACR President Lisa M. Coussens, PhD, FAACR, compared advances in cancer research to her own career journey and shared her hopes for the future of cancer research.
-
Plenary speakers explore the latest advances in the early detection and interception of cancer
Five researchers, including E. Shelley Hwang, MD, MPH, described multiple avenues of research and discovery that demonstrate how cancer can be detected and assessed early to improve patient outcomes.
-
Research advances in childhood cancers are leading to novel therapeutic approaches
Sarah K. Tasian, MD, Jezabel Rodriguez-Blanco, PhD, and Corinne M. Linardic, MD, PhD, discussed advances in pediatric cancer research and therapeutics during a Sunday afternoon symposium.
-
Five more forum sessions on tap Tuesday evening
The last five forum sessions at the Annual Meeting will examine topics including biostatistics in clinical research, engaging diverse communities in clinical trials, and overcoming cancer workforce challenges.